Revance Therapeutics Inc (RVNC)

[DewDiligence]

…I don't buy the tax selling as a root cause.

Neither do I. What has had greater impact, IMO, is selling by those who expected a quick buyout after the first FDA approval and became disenchanted when it didn’t happen. Some of these investors may not appreciate the magnitude of RVNC’s upside from therapeutic indications.